Alvogen is built on the strong foundation of Norwich Pharmaceutical Services, an U.S. company with a 130-year history and an unsurpassed regulatory track record.
CONNECT WITH US:
44 Whippany Road, Suite 300
Morristown, NJ 07960
Alvogen product portfolio is focued on complex high value generics and brands, including; niche generics, patches, controlled release and narcotics. The company currently has over 75 ANDA's in its pipeline and 28 first-to-file opportunities.
The Alvogen U.S. leadership team has a proven industry track record. Our organization structure is lean and flexible, driving quick and effective decision making. The U.S. team is led by Lisa Graver.
Alvogen business in the US is categorized into two major focus areas; generic pharmaceuticals and sales of third party services, such as contract manufacturing, pilot plant contract development and clinical research.
Third party contract manufacturing and development services are provided by the Company's manufacturing facility in Norwich located in New York State under the Norwich Pharmaceuticals brand.
"Despite an amazing history of growth, this business is poised for even greater success. With fantastic people and our emphasis on high value, difficult to make products, we have the right formula.”
President of Alvogen America
Alvogen has commercial operations in 20 countries, including China, Hong Kong, Iceland, India, Luxembourg, Malaysia, Malta, USA, Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam, as well as regional hubs, manufacturing and R&D capabilities in the U.S. and South Korea.